- Home
- / Centessa Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Centessa Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$15.4
2024-10-29
Market Capitalization
$2 B
2024-10-29
Revenue
$15 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| Revenue | 6.9M | 15.0M | |||
| General and administrative expense | 55.2M | 53.7M | 50.8M | 50.5M | |
| Operating expense total | 210.3M | 178.1M | 201.1M | 222.7M | |
| EBIT | (212.3M) | (171.3M) | (201.1M) | (207.7M) | |
| EBIT margin, % | -2499.4% | -1384.6% | |||
| Interest income | 14.0M | 20.5M | |||
| Interest expense | 7.0M | 9.9M | 10.1M | ||
| Pre tax profit | (217.0M) | (176.1M) | (232.9M) | (195.7M) | |
| Income tax expense | 114.0K | (747.0K) | (25.1M) | 2.8M | 1.8M |
| Net Income | (216.2M) | (151.1M) | (235.8M) | (197.5M) | |
| EPS | (2.3) | (1.6) | (2.1) | (1.5) |